ES417157A1 - Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe. - Google Patents

Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe.

Info

Publication number
ES417157A1
ES417157A1 ES417157A ES417157A ES417157A1 ES 417157 A1 ES417157 A1 ES 417157A1 ES 417157 A ES417157 A ES 417157A ES 417157 A ES417157 A ES 417157A ES 417157 A1 ES417157 A1 ES 417157A1
Authority
ES
Spain
Prior art keywords
cultures
virus
mutants
strains
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES417157A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of ES417157A1 publication Critical patent/ES417157A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES417157A 1972-07-21 1973-07-21 Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe. Expired ES417157A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7226337A FR2201876B1 (fr) 1972-07-21 1972-07-21

Publications (1)

Publication Number Publication Date
ES417157A1 true ES417157A1 (es) 1976-03-01

Family

ID=9102179

Family Applications (1)

Application Number Title Priority Date Filing Date
ES417157A Expired ES417157A1 (es) 1972-07-21 1973-07-21 Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe.

Country Status (12)

Country Link
JP (1) JPS4980229A (fr)
BE (1) BE802649A (fr)
CA (1) CA1030872A (fr)
CH (1) CH613229A5 (fr)
DD (1) DD107719A5 (fr)
DE (1) DE2337134A1 (fr)
ES (1) ES417157A1 (fr)
FR (1) FR2201876B1 (fr)
GB (1) GB1443958A (fr)
IL (1) IL42749A0 (fr)
NL (1) NL7310127A (fr)
ZA (1) ZA734817B (fr)

Also Published As

Publication number Publication date
FR2201876B1 (fr) 1975-11-28
IL42749A0 (en) 1973-10-25
NL7310127A (fr) 1974-01-23
DE2337134A1 (de) 1974-02-14
CH613229A5 (en) 1979-09-14
CA1030872A (fr) 1978-05-09
GB1443958A (en) 1976-07-28
JPS4980229A (fr) 1974-08-02
DD107719A5 (fr) 1974-08-12
AU5817173A (en) 1975-01-23
BE802649A (fr) 1974-01-21
FR2201876A1 (fr) 1974-05-03
ZA734817B (en) 1974-06-26

Similar Documents

Publication Publication Date Title
Moss et al. Long‐term T‐cell‐mediated immunity to Epstein‐Barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytes
Kilbourne Recombination of influenza A viruses of human and animal origin
Carp et al. A comparison of the replication cycles of simian virus 40 in human diploid and African green monkey kidney cells
Rowe et al. Additional serotypes of the APC virus group
Westaway The neutralization of arboviruses: II. Neutralization in heterologous virus-serum mixtures with four group B arboviruses
Rziha et al. BK virus: I. Seroepidemiologic studies and serologic response to viral infection
McMillen et al. Immunological reactivity of antisera to sodium dodecyl sulfate-derived polypeptides of polyoma virions
Kilbourne et al. Antibody response in man to influenza virus neuraminidase following influenza
Beard Infectious bronchitis virus interference with Newcastle disease virus in monolayers of chicken kidney cells
ES417157A1 (es) Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe.
Rabinowitz et al. The formation of variants with a reversion of properties of transformed cells: IV. Loss of detectable polyoma transplantation antigen
EP0157528A2 (fr) Souche atténuée et vaccinante de variole
IE40180L (en) Influenza virus vaccines.
ES449941A1 (es) Un metodo de preparacion de un nuevo virus vivo de la rabia.
CN107603957B (zh) 一种高效扩增j亚群禽白血病病毒的方法
DK0592636T3 (da) Fremgangsmåde til fremstilling af en levedygtig cellekultur, der er inficeret med en med dissemineret sklerose forbundet vi
Burnet et al. Study of a strain of influenza B virus isolated by chick-embryo inoculation.
Burnet et al. Reversion to virulence in an influenza virus mutant.
SU639941A1 (ru) Способ обнаружени вируса гриппа
Ledinko et al. Poliomyelitis viruses in tissue culture. III. Susceptibility of testicular tissue from immune monkeys.
Cairns The limited growth of influenza viruses in the mouse brain.
REGINSTER Inactivation of influenza virus by caseinase C from Streptomyces albus G culture-filtrate
Pedersen Jr et al. Chromatography of Venezuelan equine encephalomyelitis virus strains on calcium phosphate
Bose et al. Separation of Sindbis virus plaque-type variants by calcium phosphate chromatography
Bukrinskaya et al. The intracellular site of RNA synthesis of Newcastle disease virus